Orthopedic Trauma Devices Market
Orthopedic trauma is a condition that includes injuries mainly affecting the human skeletal system thereby, limiting smooth mobility of the person affected and reduces quality of life. It includes the conditions ranging from simple fracture to severe life threatening injuries caused, due to accidents or other fatal incidences. Orthopedic trauma includes multiple broken bones across different parts of the body such as hand (humerus, radius, and ulna), leg (Femur, Tibia, and fibula), feet (Tarsals, Metatarsals, and Phalanges), shoulder (clavicle and scapula), and brain that involve extensive reconstructive surgery. Various equipment and devices play a key role in reconstructive surgeries such as screws, plate system, nail system, special implants (internal fixator devices), and external fixator devices. These devices are commonly made of titanium and stainless steel.
The global orthopedic trauma devices market was valued at US$ 4.9 billion in 2016 and is expected to witness a robust CAGR of 5.3% over the forecast period (2017–2025).
Figure 1. Global Orthopedic Trauma Devices Market Value (US$ Bn), by Region, 2016
Source: Coherent Market Insights (2018)
Rising number of orthopedic trauma cases is expected to drive growth of the orthopedic trauma devices market
Trauma, which causes skeletal injury is associated with number of causes such as road accident and fall injury. Increasing number of trauma associated with road accidents and other causes is expected to propel growth of the orthopedic trauma devices market. According to Global Burden of Disease report published by Lancet in 2015, road injuries is one of leading cause amongst 20 causes of the disease burden worldwide. Rising number of fall injuries is also expected to boost orthopedic trauma devices market, as often fall injury causes dislocation and breakage of bones, which may require surgical procedure. According to World Health Organization (WHO) factsheet in 2018, each year there are around 37.3 million falls, which requires medical attention whereas estimated 646,000 individuals die from falls globally every year. Rising geriatric population would also aid in growth of the orthopedic trauma devices market, as people in this age group are more prone to bone fractures, due to fall injury and other orthopedic complications. According to a WHO factsheet, 2018, adults older than 65 years of age suffer from the greatest number of fatal falls. According to United Nation report titled World Population Prospect -the 2017 revision, global population of people aged over 60 years would rise from 962 million to 1.3 billion by 2030, which in turn could be a leading factor for increasing demand for orthopedic trauma device, over the forecast period.
Increased prevalence of osteoarthritis and orthopedic sports injury is also expected to drive growth of the orthopedic trauma devices market
Osteoarthritis forms one of the major burden of muscoskeletal disease worldwide characterized by deformations of joints, which requires surgical intervention to keep joint intact with help of supporting plates, screws, and nails. According to Arthritis Foundation report titled Arthritis, an estimated 91.2 million people in the U.S. are suffering from arthritis, whereas, 54.4 million people amongst this are diagnosed arthritis by doctors.
Increasing number of people are opting for some of the other sport, owing to increasing awareness about one’s health. This has led to increasing number of injuries associated with sport. These injuries are could be fractures and bone dislocation that need to be corrected with orthopaedic trauma devices. According to statistics by American Academics of Pediatrics, 775,000 children aged 14 years and younger are admitted in hospital emergency rooms for sports-related injuries each year.
Key players present in orthopedic trauma devices market are Stryker Corporation, Zimmer Holding Inc., Smith & Nephew, Biomet, Inc, DePuy Synthes (a Johnson & Johnson Company). Other prominent players are Braun Melsungen AG, Arthrax, Inc., Medtronic Inc., Integra LifeSciences Corporation, Orthofix International, NuVasive, and Conmed Corporation.